Liposomal Delivery Enhances the Effects of a Collagen Tripeptide-Containing Formulation on Dermal Structure and Optical Skin Parameters: A Randomized, Double-Blind, Placebo-Controlled Trial.

Summary

Both collagen tripeptide groups improved dermal collagen density, hydration, and elasticity versus placebo, with the liposomal formulation showing earlier and greater gains and uniquely reducing wrinkle area at Week 8. Skin luminance and tone evenness increased in active groups, supporting liposomal oral nutricosmetics for visible skin aging.

Key Findings

• RCT (n=75) showed both collagen tripeptide formulations improved collagen density, hydration, and elasticity versus placebo (p<0.05).
• Liposomal formulation achieved earlier and greater effects and uniquely reduced wrinkle area at Week 8 relative to placebo.
• Both active groups increased skin luminance and tone evenness; liposomal outperformed nonliposomal in elasticity at Week 8.

Clinical Implications

Clinicians can consider liposomal collagen tripeptide formulations for patients seeking noninvasive skin aging interventions; objective improvements in elasticity and wrinkle area support integration into multimodal cosmetic dermatology plans, with need for longer-term safety/efficacy data.

Limitations

• Short duration (8 weeks) and modest sample size
• Single product family; generalizability and long-term safety not established

Future Directions

Conduct longer RCTs with diverse populations, dose-ranging, and head-to-head delivery comparisons; include mechanistic biomarkers and durability of effect.